Evidence map›Paper›PMID 42671541›Full record

ArticleNeuroradiology2026

Non-invasive differentiation of diffuse midline glioma and midline glioblastoma using DCE-MRI perfusion parameters and machine learning classification in pediatric and young adult patients.

Anshika Kesari, Rakesh Kumar Gupta, Sunita Ahlawat, Rana Patir, Sandeep Vaishya, Anup Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anshika KesariCentre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, India. anshikakesari95@gmail.com.
Rakesh Kumar GuptaDepartment of Radiology and Neurosurgery, Fortis Memorial Research Institute, Gurgaon, India.
Sunita AhlawatDepartment of Pathology, Agilus Diagnostics, Fortis Memorial Research Institute, Gurgaon, India.
Rana PatirDepartment of Neurosurgery, Fortis Memorial Research Institute, Gurgaon, India.
Sandeep VaishyaDepartment of Neurosurgery, Fortis Memorial Research Institute, Gurgaon, India.
Anup SinghCentre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, India. anupsm@iitd.ac.in.ORCID https://orcid.org/0000-0001-6744-8326

Funding

Indian Council of Medical Research CAR-2024-01-000187Science and Engineering Research Board, Department of Science & Technology, Government of India CRG/2019/005032
6 · The paper itself

Abstract

purposeDiffuse midline glioma (DMG) and midline glioblastoma (mGBM) are aggressive WHO grade 4 tumors with comparable median survival of 12-18 months but require fundamentally different therapeutic approaches. DMG is molecularly defined by H3 K27-alteration, whereas mGBM lacks this alteration, however, non-invasive differentiation remains challenging due to overlapping conventional MRI features and the difficulty of obtaining tissue diagnosis from eloquent midline locations.

methodsThis retrospective study included 62 patients with histologically confirmed midline gliomas (30 mGBM, 32 DMG) evaluated with 3T MRI. Quantitative DCE-MRI perfusion parameters (rCBV, rCBF, Slope-2, K

resultsAmong the statistical features extracted from each parametric map, the 95

conclusionsQuantitative DCE-MRI perfusion analysis provides significant diagnostic value for differentiating DMG from mGBM, offering a non-invasive alternative when tissue diagnosis is not obtained. Both individual parameters and optimized multi-parametric approaches demonstrate clinically useful performance for guiding treatment decisions.

Indexed as

Diffuse midline gliomaDynamic contrast-enhanced MRIMachine learningMidline glioblastomaPerfusion parametersSequential forward selection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.